![](/img/cover-not-exists.png)
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer
Burtness, B., Gibson, M., Egleston, B., Mehra, R., Thomas, L., Sipples, R., Quintanilla, M., Lacy, J., Watkins, S., Murren, J. R., Forastiere, A. A.Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdn787
Date:
July, 2009
File:
PDF, 118 KB
english, 2009